PAR 1.69% 30.0¢ paradigm biopharmaceuticals limited..

Credit where it is due, PR and Co. have really structured things...

  1. 1,216 Posts.
    lightbulb Created with Sketch. 1375
    Credit where it is due, PR and Co. have really structured things in a way to help turn things around in the most dramatic way possible. A brilliant way to top things off will be a partnership deal. Just imagine if PR announces a China deal in the next two weeks? Unlikely, but wouldn't it just top things off nicely?

    MRI results in conjunction with all other results confirm DMOAD. I must admit that I only expected an improvement to BML at 6 months and no improvement in cartilage at 6 months since it just seemed too soon. iPPS basically now ticks all the boxes; pain and function, biomarkers, durability, mri etc. We can also expect a favourable outcome at the upcoming FDA meeting in Q1.

    GLTAH
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
(20min delay)
Last
30.0¢
Change
0.005(1.69%)
Mkt cap ! $103.1M
Open High Low Value Volume
30.0¢ 30.0¢ 29.5¢ $13.45K 44.89K

Buyers (Bids)

No. Vol. Price($)
6 74711 29.5¢
 

Sellers (Offers)

Price($) Vol. No.
30.0¢ 15115 6
View Market Depth
Last trade - 13.31pm 22/07/2024 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.